Cabotegravir sodium is a potent inhibitor of HIV integrase and is able to act on HIVADA (IC50: 2.5 nM). cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1 and is less likely to interact with other antiretroviral drugs (ARVs). Antileishmanial agent-12
Molekulargewicht:
427.34
CAS Nummer:
[1051375-13-3]
Formel:
C19H16F2N3NaO5
Target-Kategorie:
Others|||OAT|||HIV Protease
T62328
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten